CoChat

Pharmacokinetic and pharmacodynamic interactions between diltiazem and methylprednisolone in healthy volunteers

Booker, Brent M., Magee, Mindy He, Blum, Robert A., Lates, Christian D., Jusko, William J. · 2002 · Clinical Pharmacology & Therapeutics
Cited by 35

The DOI matches its Crossref record.

Abstract

Objectives: The pharmacokinetics and pharmacodynamics after administration of methylprednisolone alone, diltiazem alone, and both drugs jointly were assessed in healthy volunteers. Methods: An unblinded, controlled, fixed‐sequence, 2‐period study was carried out in 5 healthy white men who received a single dose of intravenous methylprednisolone, 0.3 mg/kg, on day 2, followed by diltiazem alone, 180 mg, on days 5, 6, and 7, with joint dosing of both drugs on day 8. Methylprednisolone and diltiazem disposition was assessed from plasma concentrations. Pharmacodynamic factors were assessed by plasma cortisol and T‐helper and T‐suppressor lymphocytes by means of extended indirect response models. Results: The clearance of methylprednisolone was significantly reduced in the presence of diltiazem (25.2 L/h versus 16.8 L/h), resulting in a longer half‐life (2.28 hours versus 3.12 hours) and increased area under the plasma concentration‐time curve (AUC) (871 ng · h/mL versus 1299 ng · h/mL). The AUC of diltiazem was unchanged in the presence of methylprednisolone. No significant intrinsic pharmacodynamic differences were observed for methylprednisolone versus methylprednisolone‐diltiazem. The 50% inhibitory concentration values were 0.446 ng/mL versus 0.780 ng/mL for cortisol, 9.20 ng/mL versus 10.7 ng/mL for T‐helper cells, and 18.5 ng/mL versus 20.9 ng/mL for T‐suppressor cells (P > .05). Greater net suppression, as indicated by the area between the effect curve and suppression ratios, was observed for the methylprednisolone‐diltiazem combination versus methylprednisolone alone, which was attributed to reduced elimination of methylprednisolone. Conclusions: Controlled‐delivery diltiazem, 180 mg, significantly increased methylprednisolone AUC and half‐life and reduced clearance, lending to greater systemic exposure to the steroid. However, significant differences between 50% inhibitory concentration values for methylprednisolone when given alone and for methylprednisolone in combination with diltiazem were not seen, which implies no change in cortisol or cell‐trafficking sensitivity in the presence of diltiazem. Clinical Pharmacology & Therapeutics (2002) 72, 370–382; doi: 10.1067/mcp.2002.127944

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1067/mcp.2002.127944

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 35

Metadata

Authors
Booker, B. M., Magee, M. H., Blum, R. A., Lates, C. D., & Jusko, W. J.
Venue
Clinical Pharmacology & Therapeutics
Publisher
Wiley
Published
2002-10
Volume
72
Issue
4
Pages
370-382
ISSN
  • 0009-9236 (ISSN-L)
  • 1532-6535
OpenAlex
W2122001979
Cited by
35
References
0
FWCI
1.45
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacokinetic and pharmacodynamic interactions between diltiazem and methylprednisolone in healthy volunteers. https://app.cochat.ai/papers/10.1067/mcp.2002.127944
The paper
Booker, B. M., Magee, M. H., Blum, R. A., Lates, C. D., & Jusko, W. J. (2002). Pharmacokinetic and pharmacodynamic interactions between diltiazem and methylprednisolone in healthy volunteers. Clinical Pharmacology & Therapeutics. https://doi.org/10.1067/mcp.2002.127944

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.